Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
Przeglad Lekarski
|
January 1, 1972
[Utility of antropological methods in recognition of the Marfan syndrome]
A Szczeklik, B Zenkteler, I Frydecka, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|
January 29, 1973
[Disorders of the cardiopulmonary function in heterozygotes with alpha 1 -antitrypsin deficiency]
A Szczeklik, K Stańkowska, I Frydecka, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
January 1, 1985
Natural killer (NK) activity in normal donors undergoing leukapheresis
I Frydecka, B Zukowska, K Kuliczkowski, et al.
Journal of the National Cancer Institute
|
June 1, 1987
Heterogeneity of human natural killer cells with respect to lectin-binding ability
I Frydecka, B Slesak, M Benczur, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|
June 18, 1979
[Prognostic factors in acute leukemia. Morphological studies of blood and bone marrow]
S Kotlarek-Haus, B Lawińska, W Brodzka, et al.
Folia Haematologica (Leipzig, Germany : 1928)
|
January 1, 1986
The relevance of clinical and laboratory data at diagnosis to survival time of chronic granulocytic leukemia patients
S Kotlarek-Haus, I Frydecka, G Koprowska, et al.
Therapia Hungarica (English Edition)
|
January 1, 1981
Evaluation of the therapeutic effect of lycurim in lymphoma
S Kotlarek-Haus, I Frydecka, Z Gatazka, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
September 14, 1999
Immunotherapy with recombinant human interleukin 2 in patients with hematological malignancies after bone marrow or peripheral blood stem cell transplantation
I Frydecka, A Kosmaczewska, D Boćko, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
January 12, 1999
Alterations in signal transducing molecule CD3 zeta in patients with neoplastic diseases
I Frydecka, P Kaczmarek, D Boćko, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|
April 20, 1992
[Activity of natural cytotoxic cells in non-Hodgkin's lymphoma]
I Frydecka, S Kotlarek-Haus, K Kuliczkowski, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
Przeglad Lekarski
|
January 1, 1972
[Utility of antropological methods in recognition of the Marfan syndrome]
A Szczeklik, B Zenkteler, I Frydecka, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|
January 29, 1973
[Disorders of the cardiopulmonary function in heterozygotes with alpha 1 -antitrypsin deficiency]
A Szczeklik, K Stańkowska, I Frydecka, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
January 1, 1985
Natural killer (NK) activity in normal donors undergoing leukapheresis
I Frydecka, B Zukowska, K Kuliczkowski, et al.
Journal of the National Cancer Institute
|
June 1, 1987
Heterogeneity of human natural killer cells with respect to lectin-binding ability
I Frydecka, B Slesak, M Benczur, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|
June 18, 1979
[Prognostic factors in acute leukemia. Morphological studies of blood and bone marrow]
S Kotlarek-Haus, B Lawińska, W Brodzka, et al.
Folia Haematologica (Leipzig, Germany : 1928)
|
January 1, 1986
The relevance of clinical and laboratory data at diagnosis to survival time of chronic granulocytic leukemia patients
S Kotlarek-Haus, I Frydecka, G Koprowska, et al.
Therapia Hungarica (English Edition)
|
January 1, 1981
Evaluation of the therapeutic effect of lycurim in lymphoma
S Kotlarek-Haus, I Frydecka, Z Gatazka, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
September 14, 1999
Immunotherapy with recombinant human interleukin 2 in patients with hematological malignancies after bone marrow or peripheral blood stem cell transplantation
I Frydecka, A Kosmaczewska, D Boćko, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
January 12, 1999
Alterations in signal transducing molecule CD3 zeta in patients with neoplastic diseases
I Frydecka, P Kaczmarek, D Boćko, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|
April 20, 1992
[Activity of natural cytotoxic cells in non-Hodgkin's lymphoma]
I Frydecka, S Kotlarek-Haus, K Kuliczkowski, et al.
Page
of 9